Skip to main content
SpringerLink
Log in

Lidocaine Transdermal — Vyteris

  • Adis R&D Profile
  • Published:
Drugs in R & D Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II

Notes

  1. 1This profile has been selected from R&D Insight™, a pharmaceutical intelligence database produced by Adis International Ltd.

References

  1. Vyteris Inc. Stopping the ‘Ouch’! Media Release: 6 May 2002. Available from URL: http://www.prnewswire.com

    Google Scholar 

  2. Zempsky W, Hoath S, Paulson D, McBride P. Lidocaine iontophoresis for safe and efficacious dermal anesthesia. Journal of Pain. 3 (Suppl 1): 52, Apr 2002 University of Connecticut, Hartford, Connecticut, USA

  3. Vyteris Inc. Vyteris, Inc. Submits New Drug Application to FDA For ‘Pain Patch’ Lidocaine-Delivery System. Media Release: 4 Jun 2002. Available from URL: http://www.vyteris.com

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lidocaine Transdermal — Vyteris. Drugs R&D 3, 361–362 (2002). https://doi.org/10.2165/00126839-200203050-00014

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00126839-200203050-00014

Keywords

Search

Navigation